Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flaviano Giorgini

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Journal of Clinical Medicine|September 6, 2019
DJ-1 in Parkinson's Disease: Clinical Insights and Therapeutic PerspectivesMariaelena Repici, Flaviano Giorgini
Genome Biology|March 19, 2005
Connecting the dots in Huntington's disease with protein interaction networksFlaviano Giorgini, Paul J Muchowski
Biochemical Society Transactions|July 24, 2012
Choosing and using Drosophila models to characterize modifiers of Huntington's diseaseEdward W Green, Flaviano Giorgini
Biotechnology Journal|August 10, 2006
Yeast as a drug discovery platform in Huntington's and Parkinson's diseasesTiago Fleming Outeiro, Flaviano Giorgini
Prion|November 5, 2011
Modeling Huntington disease in yeast: perspectives and future directionsRobert P Mason, Flaviano Giorgini
Methods in Molecular Biology (Clifton, N.J.)|June 13, 2009
Exploiting yeast genetics to inform therapeutic strategies for Huntington's diseaseFlaviano Giorgini, Paul J Muchowski
Methods in Enzymology|October 19, 2006
Screening for genetic modifiers of amyloid toxicity in yeastFlaviano Giorgini, Paul J Muchowski
Communicative & Integrative Biology|February 25, 2014
Rab11 as a modulator of synaptic transmissionFlaviano Giorgini, Joern R Steinert
Seminars in Cell & Developmental Biology|March 17, 2015
The kynurenine pathway and neurodegenerative diseaseDaniel C Maddison, Flaviano Giorgini
Plos Currents|May 8, 2014
Aggregation-prone proteins modulate huntingtin inclusion body formation in yeastRalitsa B Kantcheva, Robert Mason, Flaviano Giorgini
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Journal of Clinical Medicine|September 6, 2019
DJ-1 in Parkinson's Disease: Clinical Insights and Therapeutic PerspectivesMariaelena Repici, Flaviano Giorgini
Genome Biology|March 19, 2005
Connecting the dots in Huntington's disease with protein interaction networksFlaviano Giorgini, Paul J Muchowski
Biochemical Society Transactions|July 24, 2012
Choosing and using Drosophila models to characterize modifiers of Huntington's diseaseEdward W Green, Flaviano Giorgini
Biotechnology Journal|August 10, 2006
Yeast as a drug discovery platform in Huntington's and Parkinson's diseasesTiago Fleming Outeiro, Flaviano Giorgini
Prion|November 5, 2011
Modeling Huntington disease in yeast: perspectives and future directionsRobert P Mason, Flaviano Giorgini
Methods in Molecular Biology (Clifton, N.J.)|June 13, 2009
Exploiting yeast genetics to inform therapeutic strategies for Huntington's diseaseFlaviano Giorgini, Paul J Muchowski
Methods in Enzymology|October 19, 2006
Screening for genetic modifiers of amyloid toxicity in yeastFlaviano Giorgini, Paul J Muchowski
Communicative & Integrative Biology|February 25, 2014
Rab11 as a modulator of synaptic transmissionFlaviano Giorgini, Joern R Steinert
Seminars in Cell & Developmental Biology|March 17, 2015
The kynurenine pathway and neurodegenerative diseaseDaniel C Maddison, Flaviano Giorgini
Plos Currents|May 8, 2014
Aggregation-prone proteins modulate huntingtin inclusion body formation in yeastRalitsa B Kantcheva, Robert Mason, Flaviano Giorgini
Pageof 9